Learn about Herceptin® (trastuzumab), a targeted therapy approved for HER2+ metastatic breast cancer treatment. See full safety & Boxed Warnings for more information.

Mar 3, 2025 · Trastuzumab deruxtecan is FDA-approved for the treatment of HER2-positive metastatic breast cancers that have progressed on at least one past HER2-targeted therapy …

Trastuzumab (brand name: Herceptin) is a targeted therapy known as a monoclonal antibody, a modified version of an immune system protein, that can attach to proteins on HER2-positive …

Aug 10, 2021 · Targeted drug therapy uses medicines that are directed at (target) proteins on breast cancer cells that help them grow, spread, and live longer. Targeted drugs work to …

Dec 2, 2025 · Targeted therapy is a treatment for certain types of breast cancer. Learn about types of targeted therapy, common side effects, and more.

Oct 22, 2025 · Herceptin (chemical name: trastuzumab) is a HER2 inhibitor targeted therapy. Herceptin works against HER2-positive breast cancers by blocking the ability of the cancer …

Apr 17, 2025 · Learn how targeted therapies, including monoclonal antibodies (such as Herceptin or Trastuzumab), can be used to treat breast cancer.

Trastuzumab (Herceptin) is a targeted therapy for treating breast cancer. Find out when it's used, how it works and possible side effects.

Apr 14, 2024 · Find out all you need to know about Herceptin (trastuzumab) for early and more advanced HER2-positive breast cancer, including what to expect, outcomes, side effects, and …

Nov 30, 2025 · An accessible guide to current treatments for HER2-positive breast cancer in the United States, including targeted therapies, side-effect management, and emerging options.